Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-25-025769
Filing Date
2025-08-08
Accepted
2025-08-08 17:09:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A vxrt20250808_defa14a.htm DEFA14A 35109
  Complete submission text file 0001437749-25-025769.txt   36445
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)